COHBAR INC(NASDAQ:CWBR) stock News

CWBR Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Benzinga - Mentions: TRIB BWV DMTK RDHL ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

2 years ago - By: Benzinga - Mentions: CDIO THAR BDRX SNES ...

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

2 years ago - By: InvestorPlace - Mentions: ROI ESGL SVRE MBRX ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

2 years ago - By: CohBar, Inc.

CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)

2 years ago - By: InvestorPlace - Mentions: TCON MRAI INBS DRCT ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

2 years ago - By: InvestorPlace - Mentions: GVP SWIN TAOP AVTX ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

2 years ago - By: Kahn Swick & Foti, LLC

COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR

2 years ago - By: CohBar, Inc.

CohBar Reports Second Quarter 2023 Financial Results

2 years ago - By: CohBar, Inc.

CohBar Reports Second Quarter 2023 Financial Results

2 years ago - By: Brodsky & Smith LLC - Mentions: CIR GHL PDCE MFG ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CIRCOR International, Inc. (NYSE - CIR), CohBar, Inc. (Nasdaq – CWBR), Greenhill & Co., Inc. (NYSE – GHL), PDC Energy, Inc. (Nasdaq – PDCE)

2 years ago - By: CohBar, Inc.

Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

2 years ago - By: CohBar, Inc.

Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

2 years ago - By: Kahn Swick & Foti, LLC

COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR

2 years ago - By: Brodsky & Smith LLC - Mentions: EMBK GHL PDCE MFG ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Embark Technology, Inc. (Nasdaq – EMBK), CohBar, Inc. (Nasdaq – CWBR), Greenhill & Co., Inc. (NYSE – GHL), PDC Energy, Inc. (Nasdaq – PDCE)

2 years ago - By: CohBar, Inc.; Morphogenesis, Inc.

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

2 years ago - By: CohBar, Inc.; Morphogenesis, Inc.

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether CohBar, Inc. has obtained a Fair Price in its transaction with Morphogenesis, Inc.

2 years ago - By: InvestorPlace - Mentions: UTRS EEIQ APLM UFAB ...

COHBAR INC (CWBR) Stock News

CWBR Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Tuesday's After-Market Session

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR

CohBar Reports Second Quarter 2023 Financial Results

CohBar Reports Second Quarter 2023 Financial Results

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CIRCOR International, Inc. (NYSE - CIR), CohBar, Inc. (Nasdaq – CWBR), Greenhill & Co., Inc. (NYSE – GHL), PDC Energy, Inc. (Nasdaq – PDCE)

Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Embark Technology, Inc. (Nasdaq – EMBK), CohBar, Inc. (Nasdaq – CWBR), Greenhill & Co., Inc. (NYSE – GHL), PDC Energy, Inc. (Nasdaq – PDCE)

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Shareholder Alert: Ademi LLP investigates whether CohBar, Inc. has obtained a Fair Price in its transaction with Morphogenesis, Inc.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday